Biotech INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm November 29, 2022
Biotech Immutep Enters into Second Clinical Trial Collaboration Agreement with Merck KGaA, Darmstadt, Germany, and Pfizer for New Combination Study of its First-in-Class LAG-3 Candidate, Eftilagimod Alpha, and Avelumab to Treat Urothelial Cancer November 29, 2022
Biotech Aquestive Therapeutics Announces Publication of Crossover Food Effect Study of Diazepam Nasal Spray in Epilepsia November 29, 2022
Biotech Cidara Therapeutics Announces Two Leading Independent Proxy Advisory Firms Recommend Stockholders Vote “FOR” Proposed Reverse Stock Split November 29, 2022
Biotech Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation November 29, 2022
Biotech Eyenovia Announces $15 Million Credit Facility with Avenue Venture Debt Fund November 29, 2022
Biotech Galectin Therapeutics to Webcast Corporate Update on December 1, 2022 after Annual Meeting of Stockholders November 29, 2022
Biotech Investors who lost Money with shares of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) should contact the Shareholders Foundation in connection with the Lawsuit against Ampio Pharmaceuticals, Inc. November 29, 2022
Search
